Skip to main content

Table 2 Univariate and multivariate logistic regression models of complete response (CR) in PTCL patients

From: The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma

Covariate

Univariate analysis

Multivariate analysis

OR

95%CI

p-value

OR

95%CI

p-value

Sex, Male

1.590

1.001–2.527

0.050

   

Age, ≥ 60 years

3.257

1.927–5.505

 < 0.05*

4.031

2.021–8.041

 < 0.05*

IPI,3–5

5.818

3.561–9.506

 < 0.05*

   

ECOG,3–5

7.666

3.810–15.423

 < 0.05*

3.610

1.572–8.290

 < 0.05*

Stage,III-IV

7.195

3.955–13.088

 < 0.05*

2.737

1.255–5.969

 < 0.05*

B symptoms

2.389

1.516–3.766

 < 0.05*

   

Bone marrow

5.613

3.077–10.237

 < 0.05*

2.581

1.173–5.683

 < 0.05*

Involvement Albumin, < 35 g/L

2.993

1.742–5.141

 < 0.05*

   

EBV,Positive

2.233

1.409–3.541

0.05

2.090

1.170–3.734

 < 0.05*

Extra-nodal, > 1

3.118

1.936–5.021

 < 0.05*

   

LY(× 109/L) < 0.8

3.565

2.042–6.224

 < 0.05*

   

MONO(× 109/L) > 1

2.610

0.969–7.028

0.058

   

PLT(× 109/L) < 83

7.847

2.759–22.318

 < 0.05*

   

Elevated LDH

2.263

1.429–3.585

 < 0.05*

   

Elevated β2-MG

2.672

1.683–4.243

 < 0.05*

   

LMR ≤ 1.68

4.955

2.816–8.717

 < 0.05*

1.996

0.906–4.397

0.086

PMR ≤ 300

4.869

2.767–8.567

 < 0.05*

1.851

0.873–3.924

0.108

  1. OR odds ratio, CI confidence interval
  2. *Significantly different